IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:402-409.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0789

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buck, C.
Right arrow Articles by Feldkaemper, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buck, C.
Right arrow Articles by Feldkaemper, M.

Effects of Positive and Negative Lens Treatment on Retinal and Choroidal Glucagon and Glucagon Receptor mRNA Levels in the Chicken

Christine Buck, Frank Schaeffel, Perikles Simon, and Marita Feldkaemper

From the Section of Neurobiology of the Eye, University Eye Hospital, Tübingen, Tübingen, Germany.

PURPOSE. It has been found in the chicken that the amount of retinal glucagon mRNA increases during treatment with positive lenses. Pharmacological studies support the idea that glucagon may act as a stop signal for visually induced eye growth. To gain more insight into the functional role of glucagon, the changes of glucagon and glucagon receptor mRNA concentrations in retina and choroid over time were studied. Furthermore, the abundance of glucagon and the glucagon receptor was studied in different fundal layers (retina, retinal pigment epithelium[RPE], choroid) and the blood.

METHODS. Semiquantitative real-time RT-PCR was used to measure glucagon and glucagon receptor mRNA levels in retina and choroid after positive and negative lens treatment for 2, 6, or 24 hours, by unilateral -7- or +7-D lenses. Contralateral eyes served as the control, and completely untreated animals provided further reference data. Intravitreal colchicine injections (which are known to reduce the number of glucagon cells sharply) were used to verify that the related decline in glucagon mRNA could be measured by real-time RT-PCR.

RESULTS. In the retina, treatment with -7-D lenses induced an initial upregulation of glucagon mRNA in both eyes, followed by a significant downregulation. The treatment with +7-D lenses showed a significant but transient downregulation in the control eye superimposed on a trend toward upregulation in the treated eye. However, the changes in glucagon mRNA expression were not confined to the lens-treated eyes but were also found, although sometimes to a lesser extent, in the non–lens-covered fellow eyes. There was evidence of a transient increase in glucagon receptor mRNA levels in lens-treated eyes after either -7- or +7-D lens wear. In the choroid, no effect of imposed defocus was detected. The injection of colchicine led to the destruction of approximately 75% of the glucagon amacrine cells but the mRNA level of retinal glucagon decreased by only approximately 50%. Glucagon receptor expression was found to be higher in the RPE than the retina and choroid whereas, in the blood, glucagon and glucagon receptor mRNA expression was below detection level.

CONCLUSIONS. The observed bidirectional regulation of glucagon mRNA in correlation with the sign of imposed defocus supports the idea that glucagon may act as a stop-and-go signal for eye growth. This is in line with a previous proposal based on studies of changes of the glucagon peptide content.





This article has been cited by other articles:


Home page
Plant Physiol.Home page
D. Dembinsky, K. Woll, M. Saleem, Y. Liu, Y. Fu, L. A. Borsuk, T. Lamkemeyer, C. Fladerer, J. Madlung, B. Barbazuk, et al.
Transcriptomic and Proteomic Analyses of Pericycle Cells of the Maize Primary Root
Plant Physiology, November 1, 2007; 145(3): 575 - 588.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
E. Bertrand, C. Fritsch, S. Diether, G. Lambrou, D. Muller, F. Schaeffel, P. Schindler, K. L. Schmid, J. van Oostrum, and H. Voshol
Identification of Apolipoprotein A-I as a "STOP" Signal for Myopia
Mol. Cell. Proteomics, November 1, 2006; 5(11): 2158 - 2166.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. J. Fischer, G. Omar, N. A. Walton, T. A. Verrill, and C. G. Unson
Glucagon-Expressing Neurons within the Retina Regulate the Proliferation of Neural Progenitors in the Circumferential Marginal Zone of the Avian Eye
J. Neurosci., November 2, 2005; 25(44): 10157 - 10166.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. A. Vessey, K. A. Lencses, D. A. Rushforth, V. J. Hruby, and W. K. Stell
Glucagon Receptor Agonists and Antagonists Affect the Growth of the Chick Eye: A Role for Glucagonergic Regulation of Emmetropization?
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3922 - 3931.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. A. Vessey, D. A. Rushforth, and W. K. Stell
Glucagon- and Secretin-Related Peptides Differentially Alter Ocular Growth and the Development of Form-Deprivation Myopia in Chicks
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3932 - 3942.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Zhong, J. Ge, E. L. Smith III, and W. K. Stell
Image Defocus Modulates Activity of Bipolar and Amacrine Cells in Macaque Retina
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2065 - 2074.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology